A 3-year follow-up study of atropine treatment for progressive myopia in Europeans

BACKGROUND: Atropine is the most powerful treatment for progressive myopia in childhood. This study explores the 3-year effectiveness of atropine in a clinical setting. METHODS: In this prospective clinical effectiveness study, children with progressive myopia ≥ 1D/year or myopia ≤ −2.5D were prescr...

Descripción completa

Detalles Bibliográficos
Autores principales: Polling, Jan Roelof, Tan, Emily, Driessen, Sjoerd, Loudon, Sjoukje E., Wong, Hoi-Lam, van der Schans, Astrid, Tideman, J. Willem L., Klaver, Caroline C. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article CME
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785025/
https://www.ncbi.nlm.nih.gov/pubmed/32958872
http://dx.doi.org/10.1038/s41433-020-1122-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785025/
https://www.ncbi.nlm.nih.gov/pubmed/32958872
http://dx.doi.org/10.1038/s41433-020-1122-7

Ejemplares similares